Your 2023 Event Guide
Be part of key discussions on expanding the possibilities for conjugate drugs, widening the therapeutic index, and accelerating your novel conjugate from bench to bedside as quickly as possible alongside 120+ key decision-makers responsible for pioneering the development of these novel modalities.
Hear from the likes of Avidity Bioscience, Bicycle Therapeutics, BSP Pharmaceuticals, Dyne Therapeutics, Vincerx Pharma and many more.
|The new Google Chrome update is causing the PDF files to open on the website rather than the download. Once you have filled out the form, please click the 'download' icon on the top right corner of the file to download it.|